Guardant Health (NASDAQ:GH) Price Target Raised to $52.00
Guardant Health (NASDAQ:GH – Free Report) had its target price lifted by Morgan Stanley from $42.00 to $52.00 in a report issued on Thursday,Benzinga reports. They currently have an overweight rating on the stock. Other equities analysts have also issued research reports about the company. Canaccord Genuity Group upped their price target on Guardant Health […]
Guardant Health (NASDAQ:GH – Free Report) had its target price lifted by Morgan Stanley from $42.00 to $52.00 in a report issued on Thursday,Benzinga reports. They currently have an overweight rating on the stock. Other equities analysts have also issued research reports about the company. Canaccord Genuity Group upped their price target on Guardant Health […]
